[1]常 琪,魏韵佳,穆 琪,等.2016~2018年鲍曼不动杆菌临床分离株的 分布特征及耐药性变迁[J].医学信息,2019,32(16):119-121.[doi:10.3969/j.issn.1006-1959.2019.16.038]
　CHANG Qi,WEI Yun-jia,MU Qi,et al.Distribution Characteristics and Drug Resistance Changes of Clinical Isolates of Acinetobacter Baumannii from 2016 to 2018[J].Journal of Medical Information,2019,32(16):119-121.[doi:10.3969/j.issn.1006-1959.2019.16.038]
点击复制

2016~2018年鲍曼不动杆菌临床分离株的 分布特征及耐药性变迁()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
32卷
期数:
2019年16期
页码:
119-121
栏目:
调查分析
出版日期:
2019-08-15

文章信息/Info

Title:
Distribution Characteristics and Drug Resistance Changes of Clinical Isolates of Acinetobacter Baumannii from 2016 to 2018
文章编号:
1006-1959（2019）16-0119-03
作者:
常 琪1; 魏韵佳2; 穆 琪1; 余建华1
1.东部战区空军医院检验科，江苏 南京 210000； 2.新疆维吾尔自治区第二济困医院，新疆 乌鲁木齐 830026
Author(s):
CHANG Qi1; WEI Yun-jia2; MU Qi1; YU Jian-hua1
1.Department of Clinical Laboratory,Eastern Theater,Air Force Hospital,Nanjing 210000,Jiangsu, China; 2.Xinjiang Uygur Autonomous Region Second Jikun Hospital,Urumqi 830026,Xinjiang,China
关键词:
鲍曼不动杆菌; 抗菌药物; 耐药率
Keywords:
Key words：Acinetobacter baumannii; Antibacterial drugs; Drug resistance rate
分类号:
R446.5
DOI:
10.3969/j.issn.1006-1959.2019.16.038
文献标志码:
A
摘要:
目的 了解鲍曼不动杆菌在我院的分布特征及耐药性变迁，为临床合理选用抗菌药物提供依据。方法 采用珠海迪尔DL-96Ⅱ微生物分析仪进行细菌鉴定与药敏试验，对我院2016年1月~2018年12月临床各类标本中分离出的鲍曼不动杆菌的分布特征及耐药情况进行分析。结果 分离出551株鲍曼不动杆菌，年分离率相对稳定，但多重耐药鲍曼不动杆菌构成比上升明显，从67.28%上升到了82.21%。鲍曼不动杆菌主要分离自痰及咽拭子标本，占67.69%；感染主要发生在ICU病房、呼吸科和神经内科，其次为内分泌科和老干科。临床常用13种抗菌药物的耐药率与2016年比较，多种抗菌药物耐药率上升显著；2018年与2017年比较，耐药情况控制较好，其中米诺环素和多粘菌素B耐药率最低，分别为14.90%和16.35%；其余耐药率均大于55%。结论 鲍曼不动杆菌在我院耐药情况比较严重，对多种抗菌药物耐药率都达到了较高水平，临床应根据药敏结果和临床实际合理选用抗菌药物。
Abstract:
Abstract：Objective To understand the distribution characteristics and drug resistance changes of Acinetobacter baumannii in our hospital, and to provide a basis for clinical rational selection of antimicrobial agents.Methods The Zhuhai Deere DL-96Ⅱ microbiological analyzer was used for bacterial identification and drug susceptibility test. Analyzing the distribution characteristics and drug resistance of Acinetobacter baumannii isolated from various clinical specimens from January 2016 to December 2018 in our hospital.Results A total of 551 strains of Acinetobacter baumannii were isolated. The annual isolation rate was relatively stable, but the composition ratio of multi-drug resistant Acinetobacter baumannii increased significantly from 67.28% to 82.21%. Acinetobacter baumannii is mainly isolated from sputum and throat swab specimens, accounting for 67.69%; infection mainly occurs in ICU wards, respiratory and neurology, followed by endocrinology and cadaver. Compared with 2016, the resistance rate of 13 kinds of antibiotics commonly used in clinical practice increased significantly. The resistance rate of various antibiotics increased significantly. Compared with 2017, resistance was better controlled, among which minocycline and polymyxin B The drug resistance rate was the lowest, 14.90% and 16.35%, respectively; the remaining drug resistance rates were all greater than 55%.Conclusion The resistance of Acinetobacter baumannii in our hospital is quite serious, and the resistance rate to various antibiotics has reached a high level. The clinical application of antibiotics should be based on the results of drug susceptibility and clinical practice.

参考文献/References:

[1]周华,周建英,俞云松.中国鲍曼不动杆菌感染诊治与防控专家共识解读[J].中国循证医学杂志,2016,16(1):26-29. [2]Perez F,Hujer AM,Hujer KM,et al.Global challenge of multidrug-resistant Acinetobacter baumannii[J].Antimicrob Agents Chemother,2007,51(10):3471-3484. [3]俞云松.多重耐药鲍曼不动杆菌——21世纪革兰阴性菌的“mrsa”[J].中华临床感染病杂志,2009,2(2):65-68. [4]贺毅,吴伟元,陆坚,等.替加环素、米诺环素、多黏菌素B对碳青霉烯类敏感性降低和不敏感鲍曼不动杆菌体外抗菌活性[J].中国感染与化疗杂志,2014,14(1):42-46. [5]刘东华,胡艳华,王少敏.285例鲍曼不动杆菌对米诺环素体外药敏分析[J].国际检验医学杂志,2015,36(13):1954-1955. [6]周玉,丛玉隆,曲芬.鲍曼不动杆菌耐药机制及治疗策略研究进展[J].传染病信息,2014,27(3):184-188. [7]Gordon NC,Wareham DW.Multidrug-resistant Acinetobacter baumannii:mechanisms of virulence and resistance[J].Intern J Antimicrob Agents,2010,35(3):219-226. [8]Mammina C,Palma DM,Bonura C.Epidemiology and clonality of carbapenem-resistant Acinetobacter baumannii from an intensive care unit in Palermo,Italy[J].BMC Research Notes,2012(5):365. [9]Poirel L,Nordmann P.Carbapenem resistance in Acinetobacter baumannii:mechanisms and epidemiology[J].Clin Microbiol Infect,2006,12(9):826-836. [10]Fritsche TR,Sader HS,Toleman MA,et al.Emerging metallo-beta-lactamase-mediated resistances:a summary report from the worldwide SENTRY antimicrobial surveillance program[J].Clin Infect Dis,2005,41(Suppl 4):S276-S278. [11]Peleg AY,Seifert H,Paterson DL.Acinetobacter baumannii:emergence of a successful pathogen[J].Clin Microbiol Rev,2008,21(3):538-582. [12]陈佰义,何礼贤,胡必杰,等.中国鲍曼不动杆菌感染诊治与防控专家共识[J].中国医药科学,2012,2(8):3-8.

相似文献/References:

[1]尹利娟,杨振华,杨乐园.2014~2016年嗜麦芽窄食单胞菌感染临床分布及耐药性分析[J].医学信息,2018,31(03):128.[doi:10.3969/j.issn.1006-1959.2018.03.044]
　YIN Li-juan,YANG Zhen-hua,YANG Le-yuan.Clinical Distribution and Drug Resistance Analysis of Stenotrophomonas Maltophilia Infection from 2014 to 2016[J].Journal of Medical Information,2018,31(16):128.[doi:10.3969/j.issn.1006-1959.2018.03.044]
[2]李淑惠.鲍曼不动杆菌临床分布及耐药性分析[J].医学信息,2018,31(03):165.[doi:10.3969/j.issn.1006-1959.2018.03.061]
　LI Shu-hui.Clinical Distribution and Drug Resistance of Acinetobacter Baumannii[J].Journal of Medical Information,2018,31(16):165.[doi:10.3969/j.issn.1006-1959.2018.03.061]
[3]孙 赟,朱振国,余春兰,等.基于电子病历系统的抗菌药物分级管理系统开发及应用[J].医学信息,2018,31(07):18.[doi:10.3969/j.issn.1006-1959.2018.07.006]
　SUN Yun,ZHU Zhen-guo,YU Chun-lan,et al.Development and Application of Antibiotic Grading Management System Based on Electronic Medical Record System[J].Journal of Medical Information,2018,31(16):18.[doi:10.3969/j.issn.1006-1959.2018.07.006]
[4]严 威,靳 情.医院内泌尿道感染患者的病原菌耐药性分析[J].医学信息,2018,31(11):118.[doi:10.3969/j.issn.1006-1959.2018.11.037]
　YAN Wei,JIN Qing.Analysis of Pathogenic Bacteria Resistance of Patients with Urinary Tract Infection in Hospital[J].Journal of Medical Information,2018,31(16):118.[doi:10.3969/j.issn.1006-1959.2018.11.037]
[5]曹 蕾.医院信息化管理系统促进抗菌药物合理使用的价值分析[J].医学信息,2018,31(17):31.[doi:10.3969/j.issn.1006-1959.2018.17.010]
　CAO Lei.Value Analysis of Hospital Information Management System Promoting Rational Use of Antimicrobial Agents[J].Journal of Medical Information,2018,31(16):31.[doi:10.3969/j.issn.1006-1959.2018.17.010]
[6]王永艳,鱼兆虎.抗菌药物审批管理软件的设计与实现[J].医学信息,2019,32(12):21.[doi:10.3969/j.issn.1006-1959.2019.12.007]
　WANG Yong-yan,YU Zhao-hu.Design and Implementation of Antibacterial Drug Approval Management Software[J].Journal of Medical Information,2019,32(16):21.[doi:10.3969/j.issn.1006-1959.2019.12.007]
[7]王 蕊,陈金萍.2016~2017年脊柱手术预防用药及术后感染情况分析[J].医学信息,2018,31(24):112.[doi:10.3969/j.issn.1006-1959.2018.24.032]
　WANG Rui,CHEN Jin-ping.Analysis of Orophylactic Medication and Postoperative Infection in Spinal Surgery from 2016 to 2017[J].Journal of Medical Information,2018,31(16):112.[doi:10.3969/j.issn.1006-1959.2018.24.032]
[8]尹利娟,杨振华,杨乐园.2017年我院肠杆菌科细菌临床分布及耐药性分析[J].医学信息,2019,32(01):136.[doi:10.3969/j.issn.1006-1959.2019.01.042]
　YIN Li-juan,YANG Zhen-hua,YANG Le-yuan.Analysis of Clinical Distribution and Drug Resistance of Enterobacteriaceae in Our Hospital in 2017[J].Journal of Medical Information,2019,32(16):136.[doi:10.3969/j.issn.1006-1959.2019.01.042]
[9]李佳颖,李春霖,王玉莹,等.鲍曼不动杆菌的单药治疗及其联合使用的研究[J].医学信息,2019,32(05):48.[doi:10.3969/j.issn.1006-1959.2019.05.016]
　LI Jia-ying,LI Chun-lin,WANG Yu-ying,et al.Monotherapy of Acinetobacter Baumannii and Its Combined Use[J].Journal of Medical Information,2019,32(16):48.[doi:10.3969/j.issn.1006-1959.2019.05.016]
[10]王永宁,王瑞文,薛 郡,等.天津地区某基层医院铜绿假单胞菌的5年耐药变迁[J].医学信息,2019,32(09):124.[doi:10.3969/j.issn.1006-1959.2019.09.041]
　WANG Yong-ning,WANG Rui-wen,XUE Jun,et al.Five-year Resistance Change of Pseudomonas Aeruginosa in a Primary Hospital in Tianjin[J].Journal of Medical Information,2019,32(16):124.[doi:10.3969/j.issn.1006-1959.2019.09.041]
[11]陈金莲,刘泉波.鲍曼不动杆菌耐药机制及治疗现状的研究[J].医学信息,2022,35(03):45.[doi:10.3969/j.issn.1006-1959.2022.03.011]
　CHEN Jin-lian,LIU Quan-bo.Study on Drug Resistance Mechanism and Treatment Status of Acinetobacter Baumannii[J].Journal of Medical Information,2022,35(16):45.[doi:10.3969/j.issn.1006-1959.2022.03.011]

更新日期/Last Update: 2019-08-15